(Q54442858)

English

C terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

C terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Clostridium botulinum

1 reference

based on heuristic

inferred from title

author name string

Jae-Chul Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Hyun-Jung Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Yoshihiko Sakaguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Yumiko Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Hideyuki Arimitsu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Takao Tsuji

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Toshihiro Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Tohru Ohyama

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Tomofusa Tsuchiya

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Keiji Oguma

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

51

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

445-455

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

Development of vaccines for prevention of botulism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Roads from vaccines to therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Expression of H C Subunits from Clostridium botulinum Types C and D and Their Evaluation as Candidate Vaccine Antigens in Mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2007.TB03919.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2007.TB03919.X

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/17446685

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54442858&oldid=1795878670"